Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PROMETH VC W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PROMETH VC W CODEINE.
METHADOSE vs PROMETH VC W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Promethazine is a phenothiazine derivative with antihistaminic, sedative, antiemetic, and anticholinergic effects. Codeine is an opioid agonist; its analgesic and antitussive effects are mediated via mu-opioid receptors.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
10 mL (5 mg codeine, 6.25 mg promethazine) orally every 4-6 hours as needed, not to exceed 60 mg codeine per day.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: terminal elimination half-life is 2.5-4 hours in adults. Promethazine: terminal elimination half-life is 9-16 hours, with a mean of 12 hours.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Codeine and its metabolites are primarily excreted renally. Approximately 90% of a dose is excreted in the urine within 24 hours, with 10-15% as unchanged codeine, 40-60% as codeine-6-glucuronide, 5-15% as morphine, and 5-10% as norcodeine. Promethazine is extensively metabolized in the liver and excreted in urine and feces; about 70-80% appears in urine as metabolites and unchanged drug (less than 1% unchanged), with 20-30% in feces via biliary elimination.
Category C
Category D/X
Opioid Agonist
Opioid Agonist